NCT04251897

Brief Summary

A prototype support surface has been designed which aims to successfully redistributes the pressures exerted and provides sufficient support to human soft tissue We want to prove the effectiveness of the prototype support surface by enlisting patients in a clinical trial, where we will assess the presence of pressure ulcers, and the ability of the patients to tolerate the support surface, and also measure the pressure over time and compare them to when the patients are using standard mattresses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 29, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

September 2, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2021

Completed
Last Updated

April 28, 2022

Status Verified

April 1, 2022

Enrollment Period

12 months

First QC Date

January 29, 2020

Last Update Submit

April 26, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • PTAUC

    pressure-time area under curve

    For a maximum of 14 days (duration of trial)

  • Pressure sores - NPUAP (National Pressure Ulcer Advisory Panel) grade

    If pressure sores are present, they will be graded based on the NPUAP grade from 1-4. Location will also be recorded.

    For a maximum of 14 days (duration of trial)

Secondary Outcomes (3)

  • Patient's comfort

    For a maximum of 14 days (duration of trial)

  • Discomfort or pain

    For a maximum of 14 days (duration of trial)

  • Suggestions

    For a maximum of 14 days (duration of trial)

Study Arms (2)

Standard care mattress

ACTIVE COMPARATOR

Patient will have 2 days to familiarize with the novel support surface. Patient will be on standard care mattress. They will be turned over every 2 hours for 3 days.

Device: Novel support surface

Novel support surface

EXPERIMENTAL

After the standard care mattress, the same patient will be placed on novel support surface. They will be turned over every 2 hours for 3 days. Patient will then continue with the novel support surface and turned every 3 hours for 3 days. They will then continue with the novel support surface and turned every 4 hours for 3 days.

Device: Novel support surface

Interventions

This is a magnetorheological elastomer that can dynamically redistribute the pressure over a bony prominence to be lower than the critical closing pressure while at the same time providing sufficient support.

Novel support surfaceStandard care mattress

Eligibility Criteria

Age21 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must be immobile as assessed on the braden scale.
  • Patients must require 2 hourly turning
  • Age 21-85

You may not qualify if:

  • No existing pressure ulcers
  • No active infections, fever, or medical conditions that require constant medical attention.
  • They must also not have severe incontinence requiring the change of diapers more frequently than 4 hours
  • No significant cognitive impairment
  • Pregnant women will be excluded from the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tan Tock Seng Hospital Rehabilitation Centre

Singapore, 569766, Singapore

Location

MeSH Terms

Conditions

Pressure Ulcer

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Chin Jung Wong, MD

    Tan Tock Seng Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2020

First Posted

February 5, 2020

Study Start

September 2, 2020

Primary Completion

August 30, 2021

Study Completion

August 30, 2021

Last Updated

April 28, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations